| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/25/2004 | US6739180 Intelligent gas identification system and method thereof |
| 05/25/2004 | CA2450523A1 Methods for predicting the predisposition of an individual to total joint replacement failure |
| 05/25/2004 | CA2367847C Fluid management apparatus with format conversion |
| 05/25/2004 | CA2321691C Method for performing blood cell counts |
| 05/25/2004 | CA2314200C Device for the measurement of moisture of harvested crop |
| 05/25/2004 | CA2300601C Method and apparatus for determining the true stress and true strain behavior of a ductile polymer |
| 05/25/2004 | CA2293049C Fluid condition monitor |
| 05/25/2004 | CA2278782C Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 05/25/2004 | CA2253236C Methods and kits for the detection of endotoxin |
| 05/25/2004 | CA2176745C Nucleic acid analogs with a chelating functionality |
| 05/21/2004 | WO2004042870A2 Cartridge for packaging a sensor in a fluid calibrant |
| 05/21/2004 | WO2004042407A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) |
| 05/21/2004 | WO2004042406A1 Tel/etv6-mediated inhibition of cell proliferation |
| 05/21/2004 | WO2004042405A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) |
| 05/21/2004 | WO2004042404A1 Fret probes and methods for detecting interacting molecules |
| 05/21/2004 | WO2004042403A2 Methods, device and instrument for detection of analytes |
| 05/21/2004 | WO2004042401A1 Method of examining cancer cells and reagent therefor |
| 05/21/2004 | WO2004042400A1 Magnetic particle collecting magnetic force body and its use |
| 05/21/2004 | WO2004042399A1 Method and device for determining a concentration of ligands in an analysed sample |
| 05/21/2004 | WO2004042398A1 Method and probes for the detection of a tunor specific fusion protein |
| 05/21/2004 | WO2004042397A1 High sensitivity magnetic marker used for immune response measurement |
| 05/21/2004 | WO2004042396A1 Diagnostic assay for measuring a cell mediated immune response |
| 05/21/2004 | WO2004042395A1 Quantifying exposure to stress |
| 05/21/2004 | WO2004042394A2 Method for providing natural therapeutic agents with high therapeutic index |
| 05/21/2004 | WO2004042393A1 Medium and method for measuring the efficacy of a tumour therapy |
| 05/21/2004 | WO2004042391A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) |
| 05/21/2004 | WO2004042390A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) |
| 05/21/2004 | WO2004042388A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) |
| 05/21/2004 | WO2004042387A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
| 05/21/2004 | WO2004042386A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) |
| 05/21/2004 | WO2004042385A1 Method for determining vanishing temperature of petroleum product crystals and device therefor |
| 05/21/2004 | WO2004042380A2 Gas sensor |
| 05/21/2004 | WO2004042364A2 Assay device, system and method |
| 05/21/2004 | WO2004042363A2 In vivo imaging of e2f-regulated bioluminescent proteins |
| 05/21/2004 | WO2004042361A2 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 05/21/2004 | WO2004042360A2 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| 05/21/2004 | WO2004042359A2 Preformulation analysis and optimization |
| 05/21/2004 | WO2004042356A2 Apparatus and method to calibrate a gas detector |
| 05/21/2004 | WO2004042355A2 Semipermeable membrane-based sampling systems |
| 05/21/2004 | WO2004042353A2 Identifying therapeutic compounds based on their physical-chemical properties |
| 05/21/2004 | WO2004042352A2 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 05/21/2004 | WO2004042349A2 Method for evaluating the immunization status of a patient |
| 05/21/2004 | WO2004042347A2 Compositions and methods for detection and isolation of phosphorylated molecules |
| 05/21/2004 | WO2004042346A2 Methods and compositions for diagnosing and monitoring transplant rejection |
| 05/21/2004 | WO2004042344A2 Fabrication of a high resolution biological molecule detection device with gold electrical conductors |
| 05/21/2004 | WO2004042342A2 Nuclear pore protein nup88 as a novel target |
| 05/21/2004 | WO2004042079A1 Induction of the mitochondrial permeability transition |
| 05/21/2004 | WO2004042074A2 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 05/21/2004 | WO2004042072A2 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 05/21/2004 | WO2004042070A2 Electrical detection of dna hybridization and specific binding events |
| 05/21/2004 | WO2004042064A2 Disorders of lipid metabolism |
| 05/21/2004 | WO2004042057A1 Method of detecting gene mutation |
| 05/21/2004 | WO2004042054A1 Genetic morphisms relating to periodontal diseases |
| 05/21/2004 | WO2004042052A1 Modulating tnf (alpha) secretion |
| 05/21/2004 | WO2004042033A2 Circulating stem cells and uses related thereto |
| 05/21/2004 | WO2004042032A2 Cytogenetic abnormalities that are predictive of response to therapy for chronic lymphocytic leukemia |
| 05/21/2004 | WO2004042030A2 Displacement sandwich immuno-pcr |
| 05/21/2004 | WO2004042026A2 NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale) |
| 05/21/2004 | WO2004042023A2 Stem cell libraries |
| 05/21/2004 | WO2004042019A2 Systems for capture and analysis of biological particles and methods using the systems |
| 05/21/2004 | WO2004042009A2 Inhibition of il-17 production |
| 05/21/2004 | WO2004042004A2 Mouse model for autoimmune disorders |
| 05/21/2004 | WO2004041996A2 System for and method of positioning cells and determining cellular activity thereof |
| 05/21/2004 | WO2004041994A1 Rapid cell block embedding method and apparatus |
| 05/21/2004 | WO2004041867A2 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | WO2004041865A2 Stabilized single domain antibodies |
| 05/21/2004 | WO2004041863A2 Single domain antibodies directed against interferon- gamma and uses therefor |
| 05/21/2004 | WO2004041862A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | WO2004041857A2 Mutant of clostridium difficile toxin b and methods of use |
| 05/21/2004 | WO2004041842A2 Epitopes of hepatitis c virus |
| 05/21/2004 | WO2004041779A2 Amyloid plaque formation by glycosaminoglycans |
| 05/21/2004 | WO2004041778A2 A method for increasing synaptic growth or plasticity |
| 05/21/2004 | WO2004041752A2 Chemical encoding technology for combinatorial synthesis |
| 05/21/2004 | WO2004041749A1 Colouring masonry surfaces |
| 05/21/2004 | WO2004041299A1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 05/21/2004 | WO2004041213A2 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 05/21/2004 | WO2004041212A2 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | WO2004041204A2 Methods and compositions for treating neurodegenerative diseases |
| 05/21/2004 | WO2004041202A2 Analysis of pharmaceutical solubility and stability |
| 05/21/2004 | WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5 |
| 05/21/2004 | WO2004041192A2 Panels of molecular targets differentially expressed during cd8+ t-cell priming |
| 05/21/2004 | WO2004041177A2 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 05/21/2004 | WO2004041160A2 Methods and animal model for analyzing age-related macular degeneration |
| 05/21/2004 | WO2004041152A2 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 05/21/2004 | WO2004041084A1 Indirect calorimeter |
| 05/21/2004 | WO2004041076A2 Methods of detecting colorectal cancer |
| 05/21/2004 | WO2004041067A2 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | WO2004041061A2 Substrates, devices, and methods for cellular assays |
| 05/21/2004 | WO2004040970A1 Model animal of human hematopoietic organ tumor |
| 05/21/2004 | WO2004034061A3 Method for determining the susceptibility of a subject to infection |
| 05/21/2004 | WO2004027020A9 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 05/21/2004 | WO2004025344A8 Method of manufacturing of a diffraction grating-based optical identification element |
| 05/21/2004 | WO2004024087A9 Methods of diagnosing and treating hyperproliferative disorders |
| 05/21/2004 | WO2004022769A3 Means of detecting neurodegenerative processes and applications of same |
| 05/21/2004 | WO2004021014A3 Cox-2 mediated altered prostaglandin balance in diabetes complications |
| 05/21/2004 | WO2004017376A3 Integrated system for printing, processing, and imaging protein microarrays |
| 05/21/2004 | WO2004014222A3 Diagnosis and treatment of tuberous sclerosis |
| 05/21/2004 | WO2004013658A3 Method and apparatus for multiple labeling detection and evaluation of a plurality of particles |
| 05/21/2004 | WO2004013610A3 Method of measuring molecular interactions |
| 05/21/2004 | WO2004011905A8 Quality assurance/quality control for electrospray ionization processes |